The global systemic aspergillosis and systemic candidiasis market is expected to reach US$ 8,247.5 million by 2027 from US$ 6,056.3 million in 2019. The market is estimated to grow at a CAGR of 3.93% from 2019 to 2027. Rise in prevalence of fungal diseases and increase in incidence of hospital-acquired fungal infection are driving the market. However, increasing resistance to antifungal drugs and side effects of antifungal drugs is likely to hamper the growth of the market during the forecast period.
Candida Auris is a fungus that causes a serious global health threat. It causes severe illness in hospitalized patients in several countries, including the US. Patients can remain colonized with C. Auris for a long time. Also, C. Auris can persist on surfaces in healthcare environments. This can result in the spread of C. Auris between patients in healthcare facilities. According to a CDC report of 2021, US cases of C. Auris have been found in patients who had recent stays in healthcare facilities in Egypt, India, Kenya, Kuwait, Pakistan, South Africa, South Korea, the UAE, and Venezuela, which also have documented cases. Thus, this can be a hospital-acquired infection. The emergence of Candida Auris is considered as one of the most serious problems associated with nosocomial transmission and infection control practices in the hospital environment. Additionally, the CDC stated that 560 cases of C. Auris infections were reported in the US as of January 31, 2019. Furthermore, despite execution of countermeasures to limit fungal infections in intensive care units (ICUs), cases continue to be observed and reported, with a tendency toward an endemic pattern. This shows the ability of C. Auris to persistent infection in the clinical environment, enabling its transmission within the critical care setting. Unlike other Candida species, C. Auris can colonize different anatomical sites (e.g., skin, axilla, rectum, and stool) and contaminate the hospital equipment and surfaces, creating a vicious cycle of spreading, acquisition, and infection, particularly in ICUs.
Additionally, according to an NCBI report published in Jan 2020, increasing number of travels to foreign countries and exposure to healthcare in countries with extensive C. Auris transmission as well as the higher flow of migrants, are factors that can contribute to the quick dissemination of this species. Further, a higher frequency of C. Auris was found in public hospitals as compared to the private ones, which may be connected to overcrowding and compromised infection control measures. Moreover, 7 out of every 1,000 patients admitted in ICUs across India are affected with a fungal infection, says preliminary analysis of data collected by researchers in Post Graduate Institute of Medical Education and Research, Chandigarh. The data was collected from 27 hospital ICUs across the country (11 government hospitals and 16 private hospitals). Thus, increasing incidence of hospital-acquired fungal infection is creating the demand for drugs that can prevent systemic aspergillosis and systemic candidiasis. This, in turn, is likely to boost the growth of the market.
The global systemic aspergillosis and systemic candidiasis market is segmented based on type and application. Based on type, the market is segmented into voriconazole, liposomal amphotericin b, systemic oral azoles, topical antifungal agents, and others. In 2019, the systemic oral azoles segment held the largest share of the market. The same segment is expected to grow at the fastest rate during the forecast period owing to rising number of invasive fungal infections. Based on application, the global systemic aspergillosis and systemic candidiasis market is segmented into chronic pulmonary aspergillosis (CPA), allergic bronchopulmonary aspergillosis (ABPA), gastrointestinal candidiasis, genitourinary tract, candidiasis, and others. In 2019, the allergic bronchopulmonary aspergillosis (ABPA) segment held the largest share of the market. The same segment is expected to grow at the fastest rate during the forecast period.
Post Graduate Institute of Medical Education and Research, International Society for Human and Animal Mycology, Food and Drug Administration, and World Health Organization are among the essential secondary sources referred to while preparing this report.
Candida Auris is a fungus that causes a serious global health threat. It causes severe illness in hospitalized patients in several countries, including the US. Patients can remain colonized with C. Auris for a long time. Also, C. Auris can persist on surfaces in healthcare environments. This can result in the spread of C. Auris between patients in healthcare facilities. According to a CDC report of 2021, US cases of C. Auris have been found in patients who had recent stays in healthcare facilities in Egypt, India, Kenya, Kuwait, Pakistan, South Africa, South Korea, the UAE, and Venezuela, which also have documented cases. Thus, this can be a hospital-acquired infection. The emergence of Candida Auris is considered as one of the most serious problems associated with nosocomial transmission and infection control practices in the hospital environment. Additionally, the CDC stated that 560 cases of C. Auris infections were reported in the US as of January 31, 2019. Furthermore, despite execution of countermeasures to limit fungal infections in intensive care units (ICUs), cases continue to be observed and reported, with a tendency toward an endemic pattern. This shows the ability of C. Auris to persistent infection in the clinical environment, enabling its transmission within the critical care setting. Unlike other Candida species, C. Auris can colonize different anatomical sites (e.g., skin, axilla, rectum, and stool) and contaminate the hospital equipment and surfaces, creating a vicious cycle of spreading, acquisition, and infection, particularly in ICUs.
Additionally, according to an NCBI report published in Jan 2020, increasing number of travels to foreign countries and exposure to healthcare in countries with extensive C. Auris transmission as well as the higher flow of migrants, are factors that can contribute to the quick dissemination of this species. Further, a higher frequency of C. Auris was found in public hospitals as compared to the private ones, which may be connected to overcrowding and compromised infection control measures. Moreover, 7 out of every 1,000 patients admitted in ICUs across India are affected with a fungal infection, says preliminary analysis of data collected by researchers in Post Graduate Institute of Medical Education and Research, Chandigarh. The data was collected from 27 hospital ICUs across the country (11 government hospitals and 16 private hospitals). Thus, increasing incidence of hospital-acquired fungal infection is creating the demand for drugs that can prevent systemic aspergillosis and systemic candidiasis. This, in turn, is likely to boost the growth of the market.
The global systemic aspergillosis and systemic candidiasis market is segmented based on type and application. Based on type, the market is segmented into voriconazole, liposomal amphotericin b, systemic oral azoles, topical antifungal agents, and others. In 2019, the systemic oral azoles segment held the largest share of the market. The same segment is expected to grow at the fastest rate during the forecast period owing to rising number of invasive fungal infections. Based on application, the global systemic aspergillosis and systemic candidiasis market is segmented into chronic pulmonary aspergillosis (CPA), allergic bronchopulmonary aspergillosis (ABPA), gastrointestinal candidiasis, genitourinary tract, candidiasis, and others. In 2019, the allergic bronchopulmonary aspergillosis (ABPA) segment held the largest share of the market. The same segment is expected to grow at the fastest rate during the forecast period.
Post Graduate Institute of Medical Education and Research, International Society for Human and Animal Mycology, Food and Drug Administration, and World Health Organization are among the essential secondary sources referred to while preparing this report.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Systemic Aspergillosis and Systemic Candidasis Market - By Type
1.3.2 Global Systemic Aspergillosis and Systemic Candidasis Market - By Application
1.3.3 Global Systemic Aspergillosis and Systemic Candidasis Market - By Geography
2. Systemic Aspergillosis And Systemic Candidasis Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Systemic Aspergillosis and Systemic Candidasis Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
4.4 Clinical Trials Phases of Products Offered by Companies
4.5 Candida Specific Products
5. Systemic Aspergillosis and Systemic Candidasis Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Fungal Diseases
5.1.2 Rising Hospital Acquired Fungal Infection
5.2 Market Restraints
5.2.1 Increasing Resistance to Antifungal Drugs
5.2.2 Side Effects of Antifungal Drugs
5.3 Market Opportunities
5.3.1 Increase in R&D Activities and Pipeline of New Drug
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis
6. Systemic Aspergillosis And Systemic Candidasis Market - Global Analysis
6.1 Global Systemic Aspergillosis And Systemic Candidasis Market Revenue Forecast And Analysis
6.2 Global Systemic Aspergillosis And Systemic Candidasis Market, By Geography - Forecast And Analysis
6.3 Market Positioning
7. Systemic Aspergillosis and Systemic Candidasis Market Analysis- by Type
7.1 Overview
7.2 Global Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)
7.3 Voriconazole
7.3.1 Overview
7.3.2 Global Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Liposomal Amphotericin B
7.4.1 Overview
7.4.2 Global Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Systemic Oral Azoles
7.5.1 Overview
7.5.2 Global Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Topical Antifungal Agents
7.6.1 Overview
7.6.2 Global Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Systemic Aspergillosis and Systemic Candidasis Market Analysis- by Application
8.1 Overview
8.2 Global Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)
8.3 Chronic Pulmonary Aspergillosis (CPA)
8.3.1 Overview
8.3.2 Global Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Allergic Bronchopulmonary Aspergillosis (ABPA)
8.4.1 Overview
8.4.2 Global Allergic bronchopulmonary aspergillosis (ABPA) Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Gastrointestinal Candidiasis
8.5.1 Overview
8.5.2 Global Gastrointestinal Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Genitourinary Tract Candidiasis
8.6.1 Overview
8.6.2 Global Genitourinary Tract Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Others
8.7.1 Overview
8.7.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Systemic Aspergillosis and Systemic Candidiasis Market - Geographic Analysis
9.1 North America: Systemic Aspergillosis and Systemic Candidiasis Market
9.1.1 Overview
9.1.2 North America: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.1.4 North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.1.5 North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
9.1.6 US: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.1.6.3 US: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.1.7 Canada: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.1.7.3 Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.1.8 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.1.8.3 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2 Europe: Systemic Aspergillosis and Systemic Candidiasis Market
9.2.1 Overview
9.2.2 Europe: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.4 Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.5 Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
9.2.6 Germany: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.6.3 Germany: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.7 UK: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.1 UK: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.2 UK: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.7.3 UK: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.8 France: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.8.3 France: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.9 Italy: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Italy: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Italy: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.9.3 Italy: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.10 Spain: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Spain: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Spain: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.10.3 Spain: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.2.11 Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.1 Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.2 Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.2.11.3 Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3 Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market
9.3.1 Overview
9.3.2 Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.4 Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.5 Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
9.3.6 China: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.6.3 China: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.7 Japan: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.7.3 Japan: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.8 India: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.8.3 India: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.9 Australia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.1 Australia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.2 Australia: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.9.3 Australia: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.10 South Korea: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.1 South Korea: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.2 South Korea: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.10.3 South Korea: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.3.11 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.11.1 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.3.11.2 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.3.11.3 Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.4 Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market
9.4.1 Overview
9.4.2 Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.4.4 Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.4.5 Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
9.4.6 South Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.1 South Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.2 South Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.4.6.3 South Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.4.7 Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.1 Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.2 Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.4.7.3 Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.4.8 UAE: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.1 UAE: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.2 UAE: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.4.8.3 UAE: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.4.9 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.9.1 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.4.9.2 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.4.9.3 Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.5 South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market
9.5.1 Overview
9.5.2 South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.5.4 South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.5.5 South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.5.6.3 Brazil: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.5.7 Argentina: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.5.7.3 Argentina: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
9.5.8 Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.1 Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.2 Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018-2027 (USD Million)
9.5.8.3 Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018-2027 (USD Million)
10. Impact of COVID-19 Pandemic on Global Systemic Aspergillosis and Systemic Candidiasis Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment Of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Systemic Aspergillosis and Systemic Candidiasis Market-Industry Landscape
11.1 Overview
11.2 Recent Growth Strategies In The Systemic Aspergillosis And Systemic Candidiasis Market
12. Company Profiles
12.1 Novartis AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sanofi
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Pfizer Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Merck & Co., Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bayer AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Astellas Pharma Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 GlaxoSmithKline plc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Abbott
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Cipla Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 ENZON PHARMACEUTICALS, INC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of TermsList of Tables
Table 1. Clinical Trials Phases of Products Offered by Companies
Table 2. Candida Specific Products
Table 3. Clinical cases of Candida auris reported by U.S. states, as of November 30, 2020
Table 4. North America Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 5. North America Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 6. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 7. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027
Table 8. Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 9. Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 12. Europe Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 13. Europe Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 14. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 15. Germany: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027
Table 16. UK: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 17. UK: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 18. France: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 19. France: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. Italy: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 21. Italy: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 22. Spain: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 23. Spain: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 24. Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 25. Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 26. Asia PacificSystemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 27. Asia PacificSystemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 28. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 29. China: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027
Table 30. Japan: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 31. Japan: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 32. India: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 33. India: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 34. Australia: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 35. Australia: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 36. South Korea: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 37. South Korea: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 38. Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 39. Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 40. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 41. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 42. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 43. South Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027
Table 44. Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 45. Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 46. UAE: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 47. UAE: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 48. Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 49. Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 50. South and Central America Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 51. South and Central America Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 52. US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 53. Brazil: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027
Table 54. Argentina: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 55. Argentina: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 56. Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 57. Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 58. Glossary of Terms, Systemic Aspergillosis And Systemic Candidiasis MarketList of Figures
Figure 1. Systemic Aspergillosis And Systemic Candidasis Market Segmentation
Figure 2. Systemic Aspergillosis And Systemic Candidasis Market, By Region
Figure 3. Global Systemic Aspergillosis And Systemic Candidasis Market Overview
Figure 4. Systemic Oral Azoles Segment Held Largest Share of Type Segment In Systemic Aspergillosis And Systemic Candidasis Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Systemic Aspergillosis And Systemic Candidasis Market, By Geography (USD Million)
Figure 7. Global Systemic Aspergillosis And Systemic Candidasis Market- Leading Country Markets (USD Million)
Figure 8. Global Systemic Aspergillosis And Systemic Candidasis Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Systemic Aspergillosis and Systemic Candidasis Market Impact Analysis of Drivers and Restraint
Figure 15. Global Systemic aspergillosis and systemic candidasis Market - Revenue Forecast And Analysis - 2019- 2027
Figure 16. Global Systemic Aspergillosis And Systemic Candidasis Market - By Geography Forecast and Analysis - 2019- 2027
Figure 17. Global Systemic Aspergillosis And Systemic Candidasis Market - By Geography Forecast and Analysis - 2019 - 2027
Figure 18. Global Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)
Figure 19. Global Voriconazole Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 20. Global Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Global Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Global Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Global others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Global Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)
Figure 25. Global Chronic pulmonary aspergillosis (CPA) Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 26. Global Allergic bronchopulmonary aspergillosis (ABPA)Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Global Gastrointestinal Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Global Genitourinary Tract Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Global others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country - Revenue (2019) (USD Million)
Figure 31. North America: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)
Figure 32. North America: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
Figure 33. US: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. Canada: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. Mexico: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country - Revenue (2019) (USD Million)
Figure 37. Europe: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)
Figure 38. Europe: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
Figure 39. Germany: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 40. UK: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. France: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. Italy: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. Spain: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. Rest of Europe: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country - Revenue (2019) (USD Million)
Figure 46. Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)
Figure 47. Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
Figure 48. China: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 49. Japan: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 50. India: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 51. Australia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. South Korea: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. Rest of Asia Pacific: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country - Revenue (2019) (USD Million)
Figure 55. Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)
Figure 56. Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
Figure 57. South Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 58. Saudi Arabia: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. UAE: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Key Country - Revenue (2019) (USD Million)
Figure 62. South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market Revenue and Forecast to 2027 (USD Million)
Figure 63. South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
Figure 64. Brazil: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 65. Argentina: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 66. Rest of South and Central America: Systemic Aspergillosis and Systemic Candidiasis Market - Revenue and Forecast to 2027 (USD Million)
Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
Figure 68. Impact of COVID-19 Pandemic on Systemic Aspergillosis And Systemic Candidiasis Market in Asia Pacific Countries
Figure 69. Impact Of COVID-19 Pandemic in Middle East and Africa Market
Figure 70. Impact Of COVID-19 Pandemic in South and Central America Market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Novartis Ag
- Sanofi-Aventis
- Pfizer, Inc
- Merck And Co. Inc
- Enzon Pharmaceuticals, Inc
- Bayer Ag
- Astellas Pharma Inc
- Glaxosmithkline Plc
- Abbott
- Cipla
Table Information
| Report Attribute | Details |
|---|---|
| Published | January 2021 |
| Forecast Period | 2019 - 2027 |
| Estimated Market Value ( USD | $ 6056.3 Million |
| Forecasted Market Value ( USD | $ 8247.5 Million |
| Compound Annual Growth Rate | 3.9% |
| Regions Covered | Global |
